Sphere Fluidics has now in-licensed another key patent family in the area of picodroplet manipulation. The patent family contains 7 international patents with some already granted. Dr Rob Marchmont, Commercial Director, stated “We are very pleased to obtain this license. It will help us drive our business forward in the area of picodroplets and microfluidics and allows us to further target key global markets, such as single cell analysis. This patent family is also available for out-licensing for certain applications”.